Cargando…
Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy?
Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a sys...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Radcliffe Cardiology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548872/ https://www.ncbi.nlm.nih.gov/pubmed/34733353 http://dx.doi.org/10.15420/icr.2021.20 |
_version_ | 1784590675775324160 |
---|---|
author | Tyler, Zaccharie Guttmann, Oliver P Savvatis, Konstantinos Jones, Daniel O’Mahony, Constantinos |
author_facet | Tyler, Zaccharie Guttmann, Oliver P Savvatis, Konstantinos Jones, Daniel O’Mahony, Constantinos |
author_sort | Tyler, Zaccharie |
collection | PubMed |
description | Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a systematic review of the literature. Medline was searched in 2020, and cohort demographics, procedural details and complications were extracted from selected studies. Four observational studies with a combined total of 496 procedures were included. TRA-EMB was most frequently performed with a sheathless MP1 guide catheter via the right radial artery. The most common complication was pericardial effusion (up to 11% in one study), but pericardial drainage for tamponade was rare (one reported case). Death and mitral valve damage have not been reported. TRA-EMB was successful in obtaining samples in 99% of reported procedures. The authors concluded that TRA-EMB is a safe and feasible alternative to TFA-EMB and the most common complication is uncomplicated pericardial effusion. |
format | Online Article Text |
id | pubmed-8548872 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Radcliffe Cardiology |
record_format | MEDLINE/PubMed |
spelling | pubmed-85488722021-11-02 Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? Tyler, Zaccharie Guttmann, Oliver P Savvatis, Konstantinos Jones, Daniel O’Mahony, Constantinos Interv Cardiol Structural Left ventricular endomyocardial biopsy (EMB) is an essential tool in the management of myocarditis and is conventionally performed via transfemoral access (TFA). Transradial access EMB (TRA-EMB) is a novel alternative and the authors sought to determine its safety and feasibility by conducting a systematic review of the literature. Medline was searched in 2020, and cohort demographics, procedural details and complications were extracted from selected studies. Four observational studies with a combined total of 496 procedures were included. TRA-EMB was most frequently performed with a sheathless MP1 guide catheter via the right radial artery. The most common complication was pericardial effusion (up to 11% in one study), but pericardial drainage for tamponade was rare (one reported case). Death and mitral valve damage have not been reported. TRA-EMB was successful in obtaining samples in 99% of reported procedures. The authors concluded that TRA-EMB is a safe and feasible alternative to TFA-EMB and the most common complication is uncomplicated pericardial effusion. Radcliffe Cardiology 2021-10-18 /pmc/articles/PMC8548872/ /pubmed/34733353 http://dx.doi.org/10.15420/icr.2021.20 Text en Copyright © 2021, Radcliffe Cardiology https://creativecommons.org/licenses/by-nc/4.0/This work is open access under the CC-BY-NC 4.0 License which allows users to copy, redistribute and make derivative works for non-commercial purposes, provided the original work is cited correctly. |
spellingShingle | Structural Tyler, Zaccharie Guttmann, Oliver P Savvatis, Konstantinos Jones, Daniel O’Mahony, Constantinos Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? |
title | Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? |
title_full | Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? |
title_fullStr | Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? |
title_full_unstemmed | Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? |
title_short | Is This the Prime Time for Transradial Access Left Ventricular Endomyocardial Biopsy? |
title_sort | is this the prime time for transradial access left ventricular endomyocardial biopsy? |
topic | Structural |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8548872/ https://www.ncbi.nlm.nih.gov/pubmed/34733353 http://dx.doi.org/10.15420/icr.2021.20 |
work_keys_str_mv | AT tylerzaccharie isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy AT guttmannoliverp isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy AT savvatiskonstantinos isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy AT jonesdaniel isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy AT omahonyconstantinos isthistheprimetimefortransradialaccessleftventricularendomyocardialbiopsy |